Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor![](https://www.oaklins.com/uploads/sites/48/2022/03/HEALTHCARE-detail.2022.jpg)
Cooper Consumer Health has sold Stardea to EA Pharma
Cooper Consumer Health has sold Stardea to EA Pharma.
Learn moreEnterprises ImportFab Inc. has been acquired by Labomar S.p.A
Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.
Learn moreXbrane Biosciences AB has aquired Primm Pharma
Xbrane Biosciences AB (Xbrane) has acquired Primm Pharma (Primm) for an undisclosed consideration.
Learn more![](/api/deal-client-photo/105706/deal-client-photo.jpg)
Sylvain Renzi
Founder, Enterprises ImportFab, Inc.
Read more![](/api/deal-client-logo/105706/deal-client-logo.png)
Reshaping industries: M&A highlights and strategic vision
QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.
Learn more![](https://d21buns5ku92am.cloudfront.net/68798/images/544504-q2%202024%20hero-0fafbe-large-1719927574.jpg)
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital